The use of cyclodextrin inclusion complexes to improve anticancer drug profiles: a systematic review

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang F, Jia K, et al. Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol. 2018;9:1253.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global health observatory. Geneva: World Health Organization; 2018 [Last accessed 2018 Jun 21. Available at who.int/gho/database/en/
   Google Scholar
• Mitra AK, Agrahari V, Mandal A, et al. Novel delivery approaches for cancer therapeutics. J Control Release. 2015;19:248–268.
   Google Scholar
• Talekar M, Tran TH, Amiji M. Translational nano-medicines: targeted therapeutic delivery for cancer and inflammatory diseases. AAPS J. 2015;17:813–827.
   PubMed Web of Science ®Google Scholar
• Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010;1805:105–117.
   PubMed Web of Science ®Google Scholar
• Chidambaram M, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci. 2011;14:67–77. DOI:10.18433/j30c7d
   PubMed Web of Science ®Google Scholar
• Aiassa V, Zoppi A, Albesa I, et al. Inclusion complexes of chloramphenicol with β-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production. Carbohydr Polym. 2015;121:320–327. DOI:10.1016/j.carbpol.2014.11.017
   PubMed Web of Science ®Google Scholar
• Jambhekar SS, Breen P. Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex. Drug Discov Today. 2016;21(2):356–362.
   PubMed Web of Science ®Google Scholar
• Loftsson T. Cyclodextrins and biopharmaceutics classification system of drugs. J Incl Phenom Macros Chem. 2002;44:63–67.
   Web of Science ®Google Scholar
• Shen YL, Yang SH, Wu LM, et al. Study on structure and characterization of inclusion complex of gossypol/beta cyclodextrin. Spectrochimica A. 2005;61:1025–1028. DOI:0.1016/j.saa.2004.04.024
   PubMed Web of Science ®Google Scholar
• Gazpio C, Sánchez M, Zubiri IXG, et al. HPLC and solubility study of the interaction between pindolol and cyclodextrins. J Pharm Biomed Anal. 2005;37:487–492.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li J, Zhang L, et al. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-β-cyclodextrin. Spectrochimica A. 2009;71:1891–1895.
   PubMed Web of Science ®Google Scholar
• Morrison PW, Connon CJ, Khutoryanskiy VV. Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability. Mol Pharm. 2013;10:756–762.
   PubMed Web of Science ®Google Scholar
• Kiser TH, Fish D, Aquilante CL, et al. Evaluation of sulfobutylether β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy. Crit Care. 2015;19:32.
   PubMed Web of Science ®Google Scholar
• Sohi S, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent development and approaches. Drug Develop Ind Pharm. 2004;30:429–448.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
   PubMed Web of Science ®Google Scholar
• Hooijmans CR, Rovers MM, De-Vries RB, et al. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.
   PubMed Web of Science ®Google Scholar
• Becherirat S, Lanhers M, Socha M, et al. The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma. Eur J Pharm Biopharm. 2013;83:560–568.
   Google Scholar
• Busuttil RA, Liu DS, Costanzo ND, et al. An orthotopic mouse model of gastric cancer invasion and metastasis. Sci Rep. 2018;8:825.
   PubMed Web of Science ®Google Scholar
• Ochiai H, Niwayama S, Masuyama K. Inhibition of experimental pulmonary metastasis in mice β-cyclodextrin-benzaldehyde. J Cancer Res Clin Oncol. 1986;112:216–220.
   PubMed Web of Science ®Google Scholar
• Oommen E, Shenoy BD, Udupa N, et al. Antitumour efficacy of cyclodextrin complexed and noisome-encapsulated plumbagin in mice bearing Melanoma B16F1. Pharm Pharmacol Commun. 1999;5:281–285.
   Google Scholar
• Krishnaswamy M, Purushothaman KK. Plumbagin-A study of its anticancer, antibacterial and antifungal properties. Indian J Exp Biol. 1980;18:876–877.
   PubMed Web of Science ®Google Scholar
• Tanaka T, MBM DA, Nelson Duran N, et al. Colorectal cancer chemoprevention by 2 β-cyclodextrin inclusion compounds of auraptene and 4ʹ-geranyloxyferulic acid. Int J Cancer. 2010;126:830–840.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Crain B, Corr M, et al. Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer. Int J Urol. 2010;17:1–12.
   Web of Science ®Google Scholar
• Tiulea C, Peev C, Brezovan D, et al. A comparison regarding antiproliferative action between soy total extract and genistein. Rom J Morphol Embryol. 2011;52:1065–1069.
   PubMed Web of Science ®Google Scholar
• Pourgholami MH, Woon L, Almajd R, et al. In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole. Cancer Lett. 2001;165:43–49.
   PubMed Web of Science ®Google Scholar
• Pourgholami MH, Akhter J, Wang L, et al. Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosis. Cancer Chemother Pharmacol. 2005;55(5):425–432.
   PubMed Web of Science ®Google Scholar
• Pourgholami MH, Yan Cai Z, Lu Y, et al. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor bearing nude mice. Clin Cancer Res. 2006;12:1928–1935.
   PubMed Web of Science ®Google Scholar
• Ehteda A, Galettis P, Chu SWL, et al. Complexation of albendazole with hydroxypropyl-β- cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice. Anticancer Res. 2012;32:3659–3666.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70:461–477.
   PubMed Web of Science ®Google Scholar
• Struh CM, Jager S, Kersten A, et al. Triterpenoids amplify anti-tumoral effects of Mistletoe extracts on murine B16.F10 melanoma in vivo. Plos One. 2013;8:e62168.
   PubMed Web of Science ®Google Scholar
• Rowinsky EK, Donehower RC. Drug therapy Paclitaxel (Taxol). New Engl J Med. 1995;15:1004–1014.
   Google Scholar
• Yao HJ, Ju RJ, Wang XX, et al. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials. 2011;32:3285–3302.
   PubMed Web of Science ®Google Scholar
• Calleja P, Espuelas S, Corrales L, et al. Pharmacokinetics and antitumor efficacy of paclitaxel cyclodextrin complexes loaded in mucus penetrating nanoparticles for oral administration. Nanomedicine. 2014;14:2109–2121.
   Google Scholar
• Song X, Wen Y, Zhu J, et al. Thermoresponsive delivery of paclitaxel by β-cyclodextrin-based Poly(N-isopropylacrylamide) star polymer via inclusion complexation. Biomacromolecules. 2016;17:3957–3963. DOI:10.1021/acs.biomac.6b01344
   PubMed Web of Science ®Google Scholar
• Cho Y, Gutierrez L, Bordonaro M, et al. Effects of propolis and gamma-cyclodextrin on intestinal neoplasia in normal weight and obese mice. Cancer Med. 2016;5:2448–2458.
   PubMed Web of Science ®Google Scholar
• U.S. National Library of Medicine. A study of LGK974 in patients with malignancies dependent on Wnt ligands, 2017. Last accessed 2017 Nov 15 clinicaltrials.gov, https://clinicaltrials.gov/ct2/show/
   Google Scholar
• Guimaraes PPG, Tan M, Tammela T, et al. Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes. J Control Release. 2018;290:75–87.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40–59.
   PubMed Web of Science ®Google Scholar
• Leite KRM, Chade DC, Sanudo A, et al. Effects of curcumin in an orthotopic murine bladder tumor model. Int Braz J Urol. 2009;35:599–606.
   PubMed Web of Science ®Google Scholar
• Sindhwani P, Hampton JA, Baig MM, et al. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J Urol. 2001;166:1498–1501.
   PubMed Web of Science ®Google Scholar
• Watanabe FT, Chade DC, Reis ST, et al. Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model. Clinics. 2011;66:2121–2124.
   PubMed Web of Science ®Google Scholar
• Paramera EI, Konteles SJ, Karathanos VT. Stability and release properties of curcumin encapsulated in Saccharomyces cerevisiae, β-cyclodextrin and modified starch. Food Chem. 2011;125:913–922.
   Web of Science ®Google Scholar
• Falke J, Parkkinen J, Vaahtera L, et al. Curcumin as treatment for bladder cancer: a preclinical study of cyclodextrin-curcumin complex and BCG as intravesical treatment in an orthotopic bladder cancer rat model. Biomed Res Int. 2018;2018:9634902.
   PubMed Web of Science ®Google Scholar
• Mangolim CS, Moriwaki C, Nogueira AC, et al. Curcumin–β-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application. Food Chem. 2014;153:361–370. DOI:10.1016/j.foodchem.2013.12.067
   PubMed Web of Science ®Google Scholar